methamphetamine has been researched along with buprenorphine in 27 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 2 (7.41) | 18.2507 |
| 2000's | 1 (3.70) | 29.6817 |
| 2010's | 9 (33.33) | 24.3611 |
| 2020's | 15 (55.56) | 2.80 |
| Authors | Studies |
|---|---|
| Asahi, T; Katsuya, T; Kuribara, H; Tadokoro, S | 1 |
| Kuribara, H; Tadokoro, S | 1 |
| Ito, S; Kita, T; Mori, T; Narita, M; Sawaguchi, T; Suzuki, T | 1 |
| Ali, SF; Binienda, ZK; Gough, B; Macedo, TR; Pereira, FC; Ribeiro, CF | 1 |
| Chiang, YC; Ho, IK; Hung, TW | 1 |
| Eastwood, EC; Phillips, TJ | 1 |
| Beck, O; Carlsson, S; Lindkvist, I; Olsson, R | 1 |
| Emadossadat, A; Kheirabadi, GR; Maracy, MR; Salehi, M; Sharbafchi, MR | 1 |
| Kim, H; Kim, J; Kim, SY; Koo, SH; Kwon, GC; Lim, J; Park, Y | 1 |
| Ahmadi, J; Razeghian Jahromi, L | 1 |
| Asadbegi, M; Etaee, F; Komaki, A; Sarihi, A; Shahidi, S; Soleimani Asl, S; Taslimi, Z | 1 |
| Ahmadi, J; Biuseh, M; Sahraian, A | 1 |
| Funai, H; Leroux, BG; Mayfield, J; Merrill, JO; Ries, R; Speaker, EC; Tsui, JI; Yakup, S | 1 |
| Islam, M | 1 |
| Gainer, DM; Miller, SC; Nahhas, RW; Silverstein, SM; Vanderhoof, SO; Vanderhoof, T; Wright, MD | 1 |
| Frost, MC; Iles-Shih, MD; Lampert, H; Tsui, JI; Williams, EC | 1 |
| Frank, CJ; Morrison, L | 1 |
| Campbell, ANC; Choo, TH; Cook, RR; Lee, JD; Nunes, EV; Pavlicova, M; Rotrosen, J; Shulman, M; Tsui, JI | 1 |
| Coulter, C; Garnier, M; Moore, C | 1 |
| Behpour, M; Maghsoudi, M; Nojavan, S | 1 |
| Khatri, UG; Shearer, RD; Winkelman, TNA | 1 |
| Abate, MA; Dai, Z; Kraner, JC; Limen, GN; Mock, AR; Smith, GS | 1 |
| Bonny, AE; Nahata, MC; Ramey, OL; Silva Almodóvar, A | 1 |
| Abeysundera, H; Branjerdporn, G; Raza, M | 1 |
| Brown, R; Chan, B; Cooper, HLF; Crane, HM; de Gijsel, D; Delaney, JA; Feinberg, J; Fredericksen, R; Friedmann, PD; Go, VF; Jenkins, WD; Korthuis, PT; Miller, WC; Mixson, LS; Pho, MT; Seal, DW; Smith, GS; Stopka, TJ; Tsui, JI; Westergaard, R; Whitney, BM; Young, AM; Zule, WA | 1 |
| Hall, W; Humphreys, K; Mueller, JF; O'Brien, JW; Prichard, J; Thai, PK; Thomas, KV; Thompson, J; Tscharke, BJ; Verhagen, R; Wang, Z; Zheng, Q | 1 |
| Blalock, K; Darnton, J; Kim, TW; Kratina-Hathaway, Z; Leroux, BG; Radick, AC; Samet, JH; Saxon, AJ; Tsui, JI | 1 |
1 review(s) available for methamphetamine and buprenorphine
| Article | Year |
|---|---|
The impact of methamphetamine/amphetamine use on receipt and outcomes of medications for opioid use disorder: a systematic review.
Topics: Buprenorphine; Humans; Methadone; Methamphetamine; Opiate Substitution Treatment; Opioid-Related Disorders | 2021 |
5 trial(s) available for methamphetamine and buprenorphine
| Article | Year |
|---|---|
The Effect of Buprenorphine on Methamphetamine Cravings.
Topics: Adolescent; Adult; Amphetamine-Related Disorders; Buprenorphine; Central Nervous System Stimulants; Craving; Humans; Male; Methamphetamine; Narcotic Antagonists; Opiate Substitution Treatment; Treatment Outcome; Young Adult | 2015 |
Comparing the effect of buprenorphine and methadone in the reduction of methamphetamine craving: a randomized clinical trial.
Topics: Adult; Amphetamine-Related Disorders; Analgesics, Opioid; Behavior, Addictive; Buprenorphine; Central Nervous System Stimulants; Craving; Double-Blind Method; Humans; Iran; Male; Methadone; Methamphetamine; Substance Withdrawal Syndrome; Time Factors; Treatment Outcome; Young Adult | 2017 |
A randomized clinical trial on the effects of bupropion and buprenorphine on the reduction of methamphetamine craving.
Topics: Adolescent; Adult; Amphetamine-Related Disorders; Analgesics, Opioid; Behavior, Addictive; Buprenorphine; Bupropion; Central Nervous System Stimulants; Craving; Dopamine Uptake Inhibitors; Double-Blind Method; Humans; Iran; Male; Methamphetamine; Middle Aged; Substance Withdrawal Syndrome; Time Factors; Treatment Outcome; Young Adult | 2019 |
Methamphetamine/amphetamine use over time among persons with opioid use disorders treated with buprenorphine/naloxone versus extended-release naltrexone.
Topics: Buprenorphine; Buprenorphine, Naloxone Drug Combination; Delayed-Action Preparations; Humans; Injections, Intramuscular; Methamphetamine; Naltrexone; Narcotic Antagonists; Opioid-Related Disorders | 2022 |
Methamphetamine use and illicit opioid use during buprenorphine treatment.
Topics: Analgesics, Opioid; Buprenorphine; Humans; Methamphetamine; Narcotic Antagonists; Opioid-Related Disorders | 2023 |
21 other study(ies) available for methamphetamine and buprenorphine
| Article | Year |
|---|---|
Effects of repeated administration of buprenorphine on ambulatory activity in mice.
Topics: Animals; Buprenorphine; Drug Tolerance; Male; Methamphetamine; Mice; Motor Activity | 1991 |
The ambulation-increasing effect of buprenorphine in mice: comparison with the effect of morphine.
Topics: Animals; Buprenorphine; Caffeine; Cocaine; Dose-Response Relationship, Drug; Drug Synergism; Haloperidol; Locomotion; Male; Methamphetamine; Mice; Morphine; Naloxone; Pilocarpine; Scopolamine | 1991 |
Effects of mu-, delta- and kappa-opioid receptor agonists on methamphetamine-induced self-injurious behavior in mice.
Topics: 3,4-Dichloro-N-methyl-N-(2-(1-pyrrolidinyl)-cyclohexyl)-benzeneacetamide, (trans)-Isomer; Analgesics, Opioid; Animals; Behavior, Animal; Benzamides; Buprenorphine; Dopamine Agents; Dose-Response Relationship, Drug; Male; Methamphetamine; Mice; Morphine; Motor Activity; Piperazines; Receptors, Opioid; Receptors, Opioid, delta; Receptors, Opioid, kappa; Receptors, Opioid, mu; Time Factors | 2006 |
Buprenorphine modulates methamphetamine-induced dopamine dynamics in the rat caudate nucleus.
Topics: Animals; Buprenorphine; Caudate Nucleus; Dopamine; Drug Interactions; Male; Methamphetamine; Rats; Rats, Sprague-Dawley | 2011 |
Development of sensitization to methamphetamine in offspring prenatally exposed to morphine, methadone and buprenorphine.
Topics: Analgesics, Opioid; Animals; Behavior, Animal; Buprenorphine; Central Nervous System Stimulants; Female; Male; Methadone; Methamphetamine; Models, Animal; Morphine; Motor Activity; Pregnancy; Prenatal Exposure Delayed Effects; Rats; Rats, Sprague-Dawley; Reward; RNA, Messenger | 2014 |
Morphine intake and the effects of naltrexone and buprenorphine on the acquisition of methamphetamine intake.
Topics: Amphetamine-Related Disorders; Animals; Buprenorphine; Choice Behavior; Female; Inbreeding; Male; Methamphetamine; Mice; Morphine; Naltrexone; Narcotic Antagonists; Selection, Genetic | 2014 |
Application of drug testing using exhaled breath for compliance monitoring of drug addicts in treatment.
Topics: Adolescent; Adult; Aged; Amphetamines; Breath Tests; Buprenorphine; Cocaine; Drug Users; Exhalation; Female; Humans; Male; Methadone; Methamphetamine; Middle Aged; Morphine; Morphine Derivatives; Patient Compliance; Substance Abuse Detection; Young Adult | 2015 |
Evaluation of an Automated Reader and Color Interpretation-Based Immunoassays for Multiplexed Drug-of-Abuse Testing in Urine.
Topics: Amphetamine; Automation; Buprenorphine; China; Cocaine; Dronabinol; Gas Chromatography-Mass Spectrometry; Illicit Drugs; Immunoassay; Mass Spectrometry; Methadone; Methamphetamine; Morphine; Sensitivity and Specificity; Substance Abuse Detection | 2017 |
The effects of methamphetamine and buprenorphine, and their interaction on anxiety-like behavior and locomotion in male rats.
Topics: Animals; Anti-Anxiety Agents; Anxiety; Buprenorphine; Central Nervous System Stimulants; Drug Interactions; Male; Maze Learning; Methamphetamine; Motor Activity; Rats, Wistar | 2017 |
Association between methamphetamine use and retention among patients with opioid use disorders treated with buprenorphine.
Topics: Adult; Buprenorphine; Central Nervous System Stimulants; Female; Humans; Male; Methamphetamine; Opiate Substitution Treatment; Opioid-Related Disorders; Recurrence; Substance Abuse Treatment Centers; Washington | 2020 |
State of the art treatment options for Pakistan's opioid, alcohol and methamphetamine crisis.
Topics: Adolescent; Afghanistan; Analgesics, Opioid; Buprenorphine; Child; Humans; Iran; Methamphetamine; Narcotic Antagonists; Opioid-Related Disorders; Pakistan | 2020 |
Exploring the Interactions between Non-Medical Methamphetamine Use and Prescribed Buprenorphine or Naltrexone in Opioid Use Disorder Treatment Retention.
Topics: Buprenorphine; Delayed-Action Preparations; Humans; Injections, Intramuscular; Methamphetamine; Naltrexone; Narcotic Antagonists; Opioid-Related Disorders; Retrospective Studies | 2021 |
Harm Reduction for Patients With Substance Use Disorders.
Topics: Adult; Buprenorphine; Contraception; Drug Overdose; Female; Harm Reduction; Heroin; Humans; Male; Methadone; Methamphetamine; Naloxone; Opioid-Related Disorders; Pregnancy; Quality of Life; Referral and Consultation; Substance-Related Disorders | 2022 |
Rapid Extraction and Qualitative Screening of 30 Drugs in Oral Fluid at Concentrations Recommended for the Investigation of DUID Cases.
Topics: 2-Propanol; 3,4-Methylenedioxyamphetamine; Alprazolam; Amphetamines; Buprenorphine; Carisoprodol; Clonazepam; Cocaine; Codeine; Dronabinol; Fentanyl; Hexanes; Hydrocodone; Hydromorphone; Lorazepam; Meprobamate; Methadone; Methamphetamine; Morphine Derivatives; N-Methyl-3,4-methylenedioxyamphetamine; Nordazepam; Oxazepam; Oxycodone; Oxymorphone; Pharmaceutical Preparations; Phencyclidine; Tandem Mass Spectrometry; Temazepam; Tramadol; Zolpidem | 2022 |
Analysis of methamphetamine, methadone, tramadol, and buprenorphine in biological samples by ion mobility spectrometry after electromembrane extraction in tandem with slug flow microextraction.
Topics: Buprenorphine; Ion Mobility Spectrometry; Liquid Phase Microextraction; Membranes, Artificial; Methadone; Methamphetamine; Tramadol | 2022 |
State level variation in substance use treatment admissions among criminal legal-referred individuals.
Topics: Analgesics, Opioid; Buprenorphine; Drug Overdose; Humans; Methamphetamine; Opiate Substitution Treatment; Opioid-Related Disorders; Referral and Consultation; Retrospective Studies; United States | 2022 |
Characterization of Unintentional Deaths Among Buprenorphine Users.
Topics: Analgesics, Opioid; Benzodiazepines; Buprenorphine; Drug Overdose; Fentanyl; Humans; Methamphetamine; Opioid-Related Disorders | 2023 |
Urine Drug Test Results Among Adolescents and Young Adults in an Outpatient Office-Based Opioid Treatment Program.
Topics: Adolescent; Analgesics, Opioid; Buprenorphine; Cocaine; Humans; Methamphetamine; Opioid-Related Disorders; Outpatients; Retrospective Studies; Substance Abuse Detection; Young Adult | 2023 |
Impact of long-acting buprenorphine injection on methamphetamine use: A retrospective cohort study.
Topics: Buprenorphine; Humans; Methamphetamine; Retrospective Studies | 2023 |
Methamphetamine use and utilization of medications for opioid use disorder among rural people who use drugs.
Topics: Analgesics, Opioid; Buprenorphine; Humans; Methadone; Methamphetamine; Opiate Substitution Treatment; Opioid-Related Disorders; Rural Population | 2023 |
Monitoring medication and illicit drug consumption in a prison by wastewater-based epidemiology: Impact of COVID-19 restrictions.
Topics: Buprenorphine; Chromatography, Liquid; COVID-19; Humans; Illicit Drugs; Methamphetamine; Prisons; Substance Abuse Detection; Substance-Related Disorders; Tandem Mass Spectrometry; Wastewater; Water Pollutants, Chemical | 2023 |